BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 34843512)

  • 21. Contribution of APC and MUTYH mutations to familial adenomatous polyposis susceptibility in Hungary.
    Papp J; Kovacs ME; Matrai Z; Orosz E; Kásler M; Børresen-Dale AL; Olah E
    Fam Cancer; 2016 Jan; 15(1):85-97. PubMed ID: 26446593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Germline mutations of the adenomatous polyposis coli (APC) gene in Algerian familial adenomatous polyposis cohort: first report.
    Khider F; Cherbal F; Boumehdi AL; Layaida K; Mahfouf H; Zebboudj F; Maaoui M
    Mol Biol Rep; 2022 May; 49(5):3823-3837. PubMed ID: 35142982
    [TBL] [Abstract][Full Text] [Related]  

  • 23. APC or MUTYH mutations account for the majority of clinically well-characterized families with FAP and AFAP phenotype and patients with more than 30 adenomas.
    Filipe B; Baltazar C; Albuquerque C; Fragoso S; Lage P; Vitoriano I; Mão de Ferro S; Claro I; Rodrigues P; Fidalgo P; Chaves P; Cravo M; Nobre Leitão C
    Clin Genet; 2009 Sep; 76(3):242-55. PubMed ID: 19793053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Next-generation sequencing with comprehensive bioinformatics analysis facilitates somatic mosaic APC gene mutation detection in patients with familial adenomatous polyposis.
    Kim B; Won D; Jang M; Kim H; Choi JR; Kim TI; Lee ST
    BMC Med Genomics; 2019 Jul; 12(1):103. PubMed ID: 31269945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microenvironmental changes in familial adenomatous polyposis during colorectal cancer carcinogenesis.
    Hisano K; Mizuuchi Y; Ohuchida K; Kawata J; Torata N; Zhang J; Katayama N; Tsutsumi C; Nakamura S; Okuda S; Otsubo Y; Tamura K; Nagayoshi K; Ikenaga N; Shindo K; Nakata K; Oda Y; Nakamura M
    Cancer Lett; 2024 May; 589():216822. PubMed ID: 38521200
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exome sequencing identifies potential novel candidate genes in patients with unexplained colorectal adenomatous polyposis.
    Spier I; Kerick M; Drichel D; Horpaopan S; Altmüller J; Laner A; Holzapfel S; Peters S; Adam R; Zhao B; Becker T; Lifton RP; Holinski-Feder E; Perner S; Thiele H; Nöthen MM; Hoffmann P; Timmermann B; Schweiger MR; Aretz S
    Fam Cancer; 2016 Apr; 15(2):281-8. PubMed ID: 26780541
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel pathogenic splice acceptor site germline mutation in intron 14 of the APC gene in a Chinese family with familial adenomatous polyposis.
    Wang D; Liang S; Zhang Z; Zhao G; Hu Y; Liang S; Zhang X; Banerjee S
    Oncotarget; 2017 Mar; 8(13):21327-21335. PubMed ID: 28423518
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of sanger and next-generation sequencing to screen for mosaic and intronic APC variants in unexplained colorectal polyposis patients.
    Elsayed FA; Tops CMJ; Nielsen M; Morreau H; Hes FJ; van Wezel T
    Fam Cancer; 2022 Jan; 21(1):79-83. PubMed ID: 33683519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low frequency of AXIN2 mutations and high frequency of MUTYH mutations in patients with multiple polyposis.
    Lejeune S; Guillemot F; Triboulet JP; Cattan S; Mouton C; ; Porchet N; Manouvrier S; Buisine MP
    Hum Mutat; 2006 Oct; 27(10):1064. PubMed ID: 16941501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of the Y165C, G382D and 1395delGGA germline mutations of the MYH gene in Italian patients with adenomatous polyposis coli and colorectal adenomas.
    Gismondi V; Meta M; Bonelli L; Radice P; Sala P; Bertario L; Viel A; Fornasarig M; Arrigoni A; Gentile M; Ponz de Leon M; Anselmi L; Mareni C; Bruzzi P; Varesco L
    Int J Cancer; 2004 May; 109(5):680-4. PubMed ID: 14999774
    [TBL] [Abstract][Full Text] [Related]  

  • 31. APC haploinsufficiency, but not CTNNB1 or CDH1 gene mutations, accounts for a fraction of familial adenomatous polyposis patients without APC truncating mutations.
    Venesio T; Balsamo A; Rondo-Spaudo M; Varesco L; Risio M; Ranzani GN
    Lab Invest; 2003 Dec; 83(12):1859-66. PubMed ID: 14691304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High frequency of MYH gene mutations in a subset of patients with familial adenomatous polyposis.
    Venesio T; Molatore S; Cattaneo F; Arrigoni A; Risio M; Ranzani GN
    Gastroenterology; 2004 Jun; 126(7):1681-5. PubMed ID: 15188161
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA methylation patterns in adenomas from FAP, multiple adenoma and sporadic colorectal carcinoma patients.
    Wynter CV; Kambara T; Walsh MD; Leggett BA; Young J; Jass JR
    Int J Cancer; 2006 Feb; 118(4):907-15. PubMed ID: 16152625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Germline mutations in APC and MUTYH are responsible for the majority of families with attenuated familial adenomatous polyposis.
    Nielsen M; Hes FJ; Nagengast FM; Weiss MM; Mathus-Vliegen EM; Morreau H; Breuning MH; Wijnen JT; Tops CM; Vasen HF
    Clin Genet; 2007 May; 71(5):427-33. PubMed ID: 17489848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Germline and somatic mutations in exon 15 of the APC gene and K-ras mutations in duodenal adenomas in patients with familial adenomatous polyposis.
    Norheim Andersen S; Løvig T; Fausa O; Rognum TO
    Scand J Gastroenterol; 1999 Jun; 34(6):611-7. PubMed ID: 10440612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low-level APC mutational mosaicism is the underlying cause in a substantial fraction of unexplained colorectal adenomatous polyposis cases.
    Spier I; Drichel D; Kerick M; Kirfel J; Horpaopan S; Laner A; Holzapfel S; Peters S; Adam R; Zhao B; Becker T; Lifton RP; Perner S; Hoffmann P; Kristiansen G; Timmermann B; Nöthen MM; Holinski-Feder E; Schweiger MR; Aretz S
    J Med Genet; 2016 Mar; 53(3):172-9. PubMed ID: 26613750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expanding the genotype-phenotype spectrum in hereditary colorectal cancer by gene panel testing.
    Rohlin A; Rambech E; Kvist A; Törngren T; Eiengård F; Lundstam U; Zagoras T; Gebre-Medhin S; Borg Å; Björk J; Nilbert M; Nordling M
    Fam Cancer; 2017 Apr; 16(2):195-203. PubMed ID: 27696107
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synonymous mutation adenomatous polyposis coliΔ486s affects exon splicing and may predispose patients to adenomatous polyposis coli/mutY DNA glycosylase mutation‑negative familial adenomatous polyposis.
    Liu WQ; Dong J; Peng YX; Li WL; Yang J
    Mol Med Rep; 2018 Dec; 18(6):4931-4939. PubMed ID: 30272267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of MYH germline mutations in Swiss APC mutation-negative polyposis patients.
    Russell AM; Zhang J; Luz J; Hutter P; Chappuis PO; Berthod CR; Maillet P; Mueller H; Heinimann K
    Int J Cancer; 2006 Apr; 118(8):1937-40. PubMed ID: 16287072
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of two novel adenomatous polyposis coli (APC) gene mutations in patients with familial adenomatous polyposis (FAP).
    Bapat B; Berk T; Mitri A; Cohen Z; Gallinger S; Stern H
    Hum Mutat; 1994; 4(4):253-6. PubMed ID: 7866403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.